- Home
- PLX vs VWAV Comparison
PLX vs VWAV Comparison
Compare PLX & VWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- VWAV
- Stock Information
- Founded
- PLX 1993
- VWAV 2024
- Country
- PLX United States
- VWAV United States
- Employees
- PLX N/A
- VWAV N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- VWAV Computer Software: Prepackaged Software
- Sector
- PLX Health Care
- VWAV Technology
- Exchange
- PLX Nasdaq
- VWAV Nasdaq
- Market Cap
- PLX 127.4M
- VWAV 158.3M
- IPO Year
- PLX 1998
- VWAV N/A
- Fundamental
- Price
- PLX $1.91
- VWAV $11.09
- Analyst Decision
- PLX Strong Buy
- VWAV
- Analyst Count
- PLX 1
- VWAV 0
- Target Price
- PLX $15.00
- VWAV N/A
- AVG Volume (30 Days)
- PLX 705.4K
- VWAV 401.2K
- Earning Date
- PLX 11-13-2025
- VWAV 08-19-2025
- Dividend Yield
- PLX N/A
- VWAV N/A
- EPS Growth
- PLX N/A
- VWAV N/A
- EPS
- PLX 0.08
- VWAV N/A
- Revenue
- PLX $61,948,000.00
- VWAV N/A
- Revenue This Year
- PLX $14.53
- VWAV N/A
- Revenue Next Year
- PLX $75.77
- VWAV N/A
- P/E Ratio
- PLX $24.60
- VWAV N/A
- Revenue Growth
- PLX 62.79
- VWAV N/A
- 52 Week Low
- PLX $0.99
- VWAV $2.06
- 52 Week High
- PLX $3.10
- VWAV $12.59
- Technical
- Relative Strength Index (RSI)
- PLX 70.20
- VWAV N/A
- Support Level
- PLX $1.52
- VWAV N/A
- Resistance Level
- PLX $1.69
- VWAV N/A
- Average True Range (ATR)
- PLX 0.08
- VWAV 0.00
- MACD
- PLX 0.03
- VWAV 0.00
- Stochastic Oscillator
- PLX 91.67
- VWAV 0.00
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About VWAV VisionWave Holdings Inc. Common Stock
VisionWave Holdings Inc is engaged in revolutionizing defense capabilities by integrating artificial intelligence (AI) and autonomous solutions across air, ground, and sea domains. Its innovations range from high-resolution radars and vision systems to radio frequency (RF) sensing technologies are seeking to redefine operational efficiency and precision for military and homeland security applications globally.